Cancer lesion tissue evaluation that optimizes the effect of boron neutron capture therapy

摘要

A method for predicting the response of BNCT using a boron preparation containing BSH-related agents and a boron preparation containing BPA, which comprises examining the expression of CD44, translation-related factors and / or LAT1 in cancer cells in a sample. And about kits. When the expression of CD44 or translation-related factors in cancer cells in the sample is high, it can be predicted that BNCT using a boron preparation containing a BSH-related drug is likely to be effective. When the expression of LAT1 in cancer cells in the sample is high, it can be predicted that BNCT using a boron preparation containing BPA is likely to be effective.